Skip to main content
    B

    Beam Therapeutics Inc (BEAM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $20.65
    -0.29 (-1.38%)

    Market Cap: $2.36B

    Last updated: Nov 17, 2026 at 4:39 PM ET

    Beam Therapeutics Inc (BEAM) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Beam Therapeutics (BEAM) has a latest price of $20.65 on Nov 17, 2026, 46.0% below its 52-week high of $38.26. Its price fell 4.9% over the past 12 months. The month-end price fell 69.3% over the 5 years through Oct 2026, a compound annual decline of 21.0%.

    Price Chart

    From Feb 2020 to Oct 2026, its highest month-end close was $128.71 in Jun 2021 and its lowest $15.83 in May 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart BEAM with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BEAM.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 29.0%, and over 6 months it fell 21.6%. The month-end price rose 28.8% over the 3 years through Oct 2026, a compound annual rate of 8.8%.

    PeriodChange
    1 month-14.6%
    3 months-29.0%
    6 months-21.6%
    12 months-4.9%
    12 months, with dividends-4.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+28.8%+8.8%
    5 years-69.3%-21.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 11.8%, and its weakest was 2022, when it fell 50.9%.

    YearCloseChange
    2026 through Oct 2026$27.23-1.8%
    2025$27.72+11.8%
    2024$24.80-8.9%
    2023$27.22-30.4%
    2022$39.11-50.9%
    2021$79.69-2.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 16.9% below its 50-day average of $24.85 and 25.7% below its 200-day average of $27.80.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$20.65
    52-week high$38.26-46.0%
    52-week low$20.23+2.1%
    50-day average$24.85-16.9%
    200-day average$27.80-25.7%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 67.7%.

    MeasureValue
    1-year beta2.22
    Largest fall, 1 year-45.5%
    Largest fall, 3 years-67.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About BEAM

    What is BEAM's 1-year price change?

    Beam Therapeutics's price fell 4.9% over the past 12 months. With dividends included, the 12-month total return was -4.9%.

    What is BEAM's 5-year price change?

    Beam Therapeutics's month-end price fell 69.3% over the 5 years through Oct 2026, a compound annual decline of 21.0%. These figures leave out dividends.

    What is BEAM's 52-week high and low?

    Beam Therapeutics's 52-week high is $38.26 and its 52-week low is $20.23. Its latest price of $20.65 on Nov 17, 2026 is 46.0% below the high.

    What is BEAM's beta?

    Beam Therapeutics's 1-year beta against the S&P 500 is 2.22, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 45.5%.

    Is the BEAM chart free?

    Yes. Advanced Charting for BEAM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.